Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by canadafanon Dec 27, 2024 7:57am
163 Views
Post# 36378147

RE:RE:RE:the doomsday clock has restarted

RE:RE:RE:the doomsday clock has restartedA lot of typos my last post. Did withiut my glasses.
point form.
oncy did not recieve the non- compliance notice, because they did not exceed the 30days, closing bellow $1.00
had they , Onc would have had to put out a N.R. Advising investors as such.
they did last time. Was about 5 yrs ago, btw.
Then the  30 days never came as the price spiked , quite well on a year end squeeze. That being a Dec of 2018.
back to now, since they closed above $1.00 the 30 day clock does indeed get reset.
someone mentioned bid/ ask price.?
both are meaningless.
The reading is daily closing price.
afterall, we all know & see, bid/ ask can be anything.
Nas clearly indicates daily closing price.
let's move past that, & look towards to the upcoming efficacy news on the latest co- therapy trial with Roche & the anal cancer results.
imagine! 3 enabling trial opportunities.
As well the late announcement of the conference Jan 11th.
Thr meet with existing & potential partners.
as they said.
lots on the go.....

<< Previous
Bullboard Posts
Next >>